Mesa Laboratories, Inc. (MLAB)

Mesa Laboratories Financials Overview

Financials in millions USD. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	249.13	249.13	240.98	216.19	219.08	184.34
Revenue Growth	3.38%	3.38%	11.47%	-1.32%	18.85%	37.63%
Gross Profit Gross Profit Growth	158.27	158.27	150.87	133.25	133.69	109.09
Operating Income Operating Income Growth	18.51	18.51	16.34	-272.08	3.32	4.7
Net Income Net Income Growth	6.71	6.71	-1.97	-254.25	0.93	1.87
Earnings Per Share EPS Growth	1.21	1.21	-0.36	-47.20	0.17	0.35
EPS Growth	-	-	-	-	-51.43%	-45.31%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Clinical Genomics Clinical Genomics Growth	45.39	45.39	47.08	52.59	62.3	32.84
Calibration Solutions Calibration Solutions Growth	53.55	53.55	51.75	47.76	44.81	46.87
Sterilization and Disinfection Control Sterilization and Disinfection Control Growth	101.57	101.57	93.42	75.12	64.61	59.04
Biopharmaceutical Development Biopharmaceutical Development Growth	48.63	48.63	48.73	40.71	47.37	45.58
Total Total Growth	249.13	249.13	240.98	216.19	219.08	184.34

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	26.93	26.93	27.32	28.21	32.91	49.35
Total Debt Total Debt Growth	151.48	151.48	177.95	221.7	183.27	218.37
Net Cash (Debt) Net Cash Growth	-124.55	-124.55	-150.63	-193.48	-150.36	-169.02
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-22.38	-22.38	-27.79	-35.92	-28.05	-31.68

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	42.83	42.83	46.81	44.13	27.98	39.22
Capital Expenditures CapEx Growth	-3.25	-3.25	-4.25	-2.57	-4.54	-4.43
Free Cash Flow Free Cash Flow Growth	39.58	39.58	42.56	41.57	23.44	34.79
Free Cash Flow Growth	-7.00%	-7.00%	2.39%	77.34%	-32.63%	-0.83%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	63.53%	63.53%	62.61%	61.64%	61.02%	59.18%
Operating Margin	7.43%	7.43%	6.78%	-125.85%	1.52%	2.55%
Pretax Margin	4.82%	4.82%	2.47%	-127.50%	-0.18%	1.94%
Profit Margin	2.69%	2.69%	-0.82%	-117.61%	0.42%	1.01%
FCF Margin	15.89%	15.89%	17.66%	19.23%	10.70%	18.87%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 1, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	0.640	0.640	0.640	0.640	0.640	0.640
Dividend Per Share Growth	0%	0%	0%	0%	0%	0%
Dividend Yield	0.63%	0.72%	0.54%	0.58%	0.37%	0.25%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 1, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	83.31	73.07	-	-	1027.82	728.23
Forward PE	74.13	63.76	16.50	17.53	27.40	39.18
P/FCF Ratio	14.25	12.34	15.21	14.24	40.03	38.58
PS Ratio	2.26	1.96	2.69	2.74	4.28	7.28

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: May 27, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error